关于百诺华
百諾華國際药業有限公司
本公司是一家注册于香港、拥有香港卫生署批准药品批发牌照的合法医药公司。我们专注于为全球客户提供合规、安全、高效的处方药、非处方药、抗衰老产品及医疗耗材,已与全球50多个国家建立长期合作关系。
我们总是乐意帮忙
无论您是终端客户、经销商,还是新晋合作伙伴,我们始终秉持专业、高效、贴心的服务理念,为全球健康贡献我们的力量。
为什么选择我们
合规资质齐全
Licensed & Compliant
持香港卫生署核发中成药及西药批发商牌照,严格遵守行业法规
Officially licensed by the HK Department of Health for both Chinese and Western pharmaceutical wholesale.
全球供应网络
Global Reach
产品出口至全球50+国家,与多家药企建立长期合作关系
Long-term export partnerships with 50+ countries and global manufacturers.
稳定冷链物流
Reliable Cold Chain Logistics
自建标准药品储藏及包装系统,保障运输安全
In-house compliant storage and cold-chain shipping system for safe delivery.
专业客服团队
Multilingual Client Support
配备多语种客户经理,提供一对一服务与售后保障
Dedicated client managers offering multilingual, personalized service and full after-sales support.



合法资质 · 政府监管认证
Regulatory Compliance & Certifications
我们持有香港卫生署核发的《中成药批发商牌照》与《西药批发商牌照》,合法从事药品批发、出口及储存业务,所有药品交易全程受香港政府卫生署监管,配套商业发票与出口资料完整可查。
We are officially licensed by the Hong Kong Department of Health for the wholesale of both Chinese and Western medicines. All pharmaceutical transactions are supervised by the HK government, with full commercial invoicing, export documentation, and regulatory tracking.
企业发展历程
Corporate development history
May 1, 2015
公司成立
百諾華國際药業有限公司在香港正式注册成立,专注国际药品贸易业务,致力于搭建全球医疗健康供应平台。
Bio Nova International Medical Limited was officially established in Hong Kong, focusing on global pharmaceutical trade and medical supply services.
January 18, 2018
获得香港西药/中成药批发商牌照
通过香港卫生署严格审核,正式取得中成药与西药批发商资格,确立合规经营根基。
Obtained the official wholesale licenses for Chinese and Western medicines from the Hong Kong Department of Health, laying the foundation for compliant operations.
March 1, 2020
出口覆盖30+国家
与全球多家制药企业建立长期合作,产品出口至亚洲、欧洲、美洲、中东等30多个国家和地区。
Established partnerships with pharmaceutical companies worldwide and expanded export coverage to over 30 countries across Asia, Europe, the Americas, and the Middle East.
July 8, 2024
上线小程序代理系统,全面数字化运营
推出微信小程序与独立H5商城,打造“分享即分销”的跨境医药销售系统,增强代理拓展能力与客户留存。
Launched WeChat mini-program and H5 e-commerce system to enable agent-based digital sales and enhance customer acquisition and retention.
January 20, 2025
品牌升级,拓展多语言国际市场
启动品牌升级计划,完善中英日三语网站,拓展海外代理渠道,提升品牌国际影响力。
Initiated brand upgrade strategy with a multilingual website (Chinese-English-Japanese), expanded international distribution channels, and elevated global brand presence.